TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2026
Back to search
Official data from USPTO
GILEAD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000088352036Class
5, 36, 40, 41, 44
Filing
88352036
Registration
6325064
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/11/2026
Trademark type
Combined
Nice classes
5, 36, 40, 41, 44
Filing date
03/22/2019
Registration date
04/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/20/2021
Last transaction
07/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/31/2004
First use in commerce
07/31/2004
Drawing code
5
Owner type
03
Owner location
Foster City, CA, US
Examiner
TENG, SIMON
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "GILEAD" in stylized font.
Holders and representatives
Holders
Gilead Sciences, Inc.
Gilead Sciences, Inc.
Representatives
Cynthia Smuzynska Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 5Class 36Class 40Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationspharmaceuticals for the treatment of viral infections; pharmaceuticals for the treatment of cardiovascular disorders and conditions; pharmaceuticals for the treatment of respiratory disorders and conditions; pharmaceuticals for the treatment of fungal diseases and disorders; pharmaceuticals for the treatment of liver disease; pharmaceuticals for the treatment of HIV/AIDS and hepatitis; pharmaceuticals for the treatment of inflammatory diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapyincluding T Cell therapy
Class 36
Financial sponsorship of sportseducational and entertainment programs and events; financial administration of patient reimbursement programs
Class 40
Custom manufacturing of biological tissuebloodcells; custom manufacturing of pharmaceutical preparations for immunotherapy
Class 41
Educational servicesconducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders
Class 44
Providing health and medical information about medical disorders and their diagnosisprevention and treatment; counseling and charitable services for patientsproviding information and assistance with respect to obtaining prescription medications
Publications
History of USPTO decisions and trademark events.
34 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/10/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/10/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/20/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/02/2021
PUBO
PUBLISHED FOR OPPOSITION
02/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/13/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/26/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/25/2020
ALIE
ASSIGNED TO LIE
06/25/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/25/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/25/2019
CNSL
SUSPENSION LETTER WRITTEN
12/25/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/24/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/24/2019
CNSL
SUSPENSION LETTER WRITTEN
06/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2019
ALIE
ASSIGNED TO LIE
06/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/01/2019
GNRT
NON-FINAL ACTION E-MAILED
06/01/2019
CNRT
NON-FINAL ACTION WRITTEN
06/01/2019
DOCK
ASSIGNED TO EXAMINER
06/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2019
NWAP
NEW APPLICATION ENTERED
03/26/2019
Continuous trademark protection
Get notified about every new filing that threatens GILEAD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.